Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
The American Journal of Psychiatry
|
November 2, 2019
Esketamine and the Need for a New Type of Registry for Drugs With Abuse Potential
Rupert McShane, David S Baldwin, R Hamish McAllister-Williams, et al.
JMIR Medical Education
|
November 1, 2023
Preliminary Evaluation of a Web-Based International Journal Club for Ketamine in Psychiatric Disorders: Cross-Sectional Survey Study
Jacek R Lindner, Ashkan Ebrahimi, Julian F Kochanowicz, et al.
The Cochrane Database of Systematic Reviews
|
September 2, 2014
Neuropsychological tests for the diagnosis of Alzheimer's disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies
Daniel Hj Davis, Sam T Creavin, Anna Noel-Storr, et al.
The Lancet. Neurology
|
January 14, 2009
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
Clive Ballard, Maria Luisa Hanney, Megan Theodoulou, et al.
The Cochrane Database of Systematic Reviews
|
March 5, 2019
AD-8 for detection of dementia across a variety of healthcare settings
Kirsty Hendry, Claire Green, Rupert McShane, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 12, 2020
Medical cannabis in the UK: From principle to practice
Anne Katrin Schlag, David S Baldwin, Michael Barnes, et al.
The Journal of Clinical Psychiatry
|
January 28, 2004
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome
Clive G Ballard, Alan Thomas, Jane Fossey, et al.
The Cochrane Database of Systematic Reviews
|
October 8, 2021
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
Rebecca L Dean, Tahnee Marquardt, Claudia Hurducas, et al.
The Cochrane Database of Systematic Reviews
|
September 12, 2021
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
Rebecca L Dean, Claudia Hurducas, Keith Hawton, et al.
The Cochrane Database of Systematic Reviews
|
September 30, 2015
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults
Tayla L McCloud, Caroline Caddy, Janina Jochim, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
The American Journal of Psychiatry
|
November 2, 2019
Esketamine and the Need for a New Type of Registry for Drugs With Abuse Potential
Rupert McShane, David S Baldwin, R Hamish McAllister-Williams, et al.
JMIR Medical Education
|
November 1, 2023
Preliminary Evaluation of a Web-Based International Journal Club for Ketamine in Psychiatric Disorders: Cross-Sectional Survey Study
Jacek R Lindner, Ashkan Ebrahimi, Julian F Kochanowicz, et al.
The Cochrane Database of Systematic Reviews
|
September 2, 2014
Neuropsychological tests for the diagnosis of Alzheimer's disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies
Daniel Hj Davis, Sam T Creavin, Anna Noel-Storr, et al.
The Lancet. Neurology
|
January 14, 2009
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
Clive Ballard, Maria Luisa Hanney, Megan Theodoulou, et al.
The Cochrane Database of Systematic Reviews
|
March 5, 2019
AD-8 for detection of dementia across a variety of healthcare settings
Kirsty Hendry, Claire Green, Rupert McShane, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 12, 2020
Medical cannabis in the UK: From principle to practice
Anne Katrin Schlag, David S Baldwin, Michael Barnes, et al.
The Journal of Clinical Psychiatry
|
January 28, 2004
A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome
Clive G Ballard, Alan Thomas, Jane Fossey, et al.
The Cochrane Database of Systematic Reviews
|
October 8, 2021
Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
Rebecca L Dean, Tahnee Marquardt, Claudia Hurducas, et al.
The Cochrane Database of Systematic Reviews
|
September 12, 2021
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
Rebecca L Dean, Claudia Hurducas, Keith Hawton, et al.
The Cochrane Database of Systematic Reviews
|
September 30, 2015
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults
Tayla L McCloud, Caroline Caddy, Janina Jochim, et al.
Page
of 7